NASDAQ:AMDA Amedica (AMDA) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free AMDA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.09▼$2.1952-Week Range$0.18▼$6.40Volume16.43 million shsAverage Volume1.07 million shsMarket Capitalization$434,442.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Amedica alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Amedica Stock (NASDAQ:AMDA)SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. AMDA Stock News HeadlinesNovember 5, 2023 | thestreet.comHere's the Best Way for Investors to Play the IPO MarketOctober 7, 2022 | globenewswire.comSilicon nitride ceramics Market 2022 | reach USD 683.74 million by 2028 - GlobeNewswireApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 27, 2022 | benzinga.comGlobal Interlaminar Device Market to Witness Growth by a CAGR of ~5% throughout 2022 – 2031 Owing to the - BenzingaFebruary 9, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 20 - BenzingaFebruary 9, 2022 | globenewswire.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 2021 to $4.9 Billion by 2026 - GlobeNewswireNovember 12, 2021 | marketscreener.comSINTX TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.comNovember 5, 2021 | finance.yahoo.comSilicon Nitride Market Research Report by Type, by End-use Industry, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo FinanceApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.November 3, 2021 | benzinga.comSpinal Devices & Biologics Market Research Report by Type, by Application, by Region - Global Forecast to - BenzingaOctober 6, 2021 | finance.yahoo.comSINTX Technologies Ships New FleX SN Porous and Laser-textured Spinal Implants - Yahoo FinanceSeptember 2, 2021 | dallasnews.comHouston tech firm lands in Addison with new office - The Dallas Morning NewsSeptember 1, 2021 | finance.yahoo.comNew Analysis from Global Industry Analysts Reveals Steady Growth for Bioceramics, with the Market to Reach $21.7 Billion Worldwide by 2026 - Yahoo FinanceAugust 12, 2021 | marketscreener.comSINTX TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.comSee More Headlines Receive AMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amedica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/21/2017Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:AMDA CUSIPN/A CIK1269026 Webwww.amedica.com Phone(855) 839-3500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,320,000.00 Net Margins-139.62% Pretax MarginN/A Return on Equity-148.60% Return on Assets-67.83% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99 Sales & Book Value Annual Sales$11.23 million Price / Sales0.04 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book0.02Miscellaneous Outstanding Shares11,870,000Free FloatN/AMarket Cap$434,442.00 OptionableNot Optionable Beta-1.24 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesB. Sonny BalChairman, President, Chief Executive Officer & CFODavid O’BrienChief Operating OfficerBryan J. McEntireChief Scientific OfficerDonald J. BrayVice President-Business DevelopmentMichael MarcroftVice President-Business DevelopmentKey CompetitorsMotus GINASDAQ:MOTSSintx TechnologiesNASDAQ:SINTBluejay DiagnosticsNASDAQ:BJDXAllarity TherapeuticsNASDAQ:ALLRObsEvaNASDAQ:OBSVView All Competitors AMDA Stock Analysis - Frequently Asked Questions How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) posted its earnings results on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative trailing twelve-month return on equity of 148.60% and a negative net margin of 139.62%. When did Amedica's stock split? Amedica's stock reverse split on the morning of Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), General Electric (GE), Net Element (NETE), Pernix Therapeutics (PTX), Synergy Pharmaceuticals (SGYP), Anavex Life Sciences (AVXL), (GBSN) (GBSN), This page (NASDAQ:AMDA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
